<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000792993">
  <TermName>Ameluz</TermName>
  <TermPronunciation>(A-meh-looz)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug that contains the active ingredient aminolevulinic acid hydrochloride and is used with photodynamic therapy to treat actinic keratosis (a skin condition that may become cancer). When Ameluz is taken up by abnormal cells, including cancer cells, and then exposed to certain types of light, it becomes active and kills the cells.  Ameluz is a type of photosensitizing agent.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000793625" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Ameluz&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000793624" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Ameluz&quot;" language="es" id="_4"/>
  <SpanishTermName>Ameluz</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que contiene el principio activo clorhidrato de ácido aminolevulínico y se utiliza en combinación con terapia fotodinámica para el tratamiento de la queratosis actínica (afección de la piel que a veces se convierte en cáncer). Las células anormales, como las células cancerosas, captan Ameluz y luego, cuando se exponen a ciertos tipos de luz, el medicamento se activa y las destruye. Ameluz es un tipo de fotosensibilizador.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2018-04-10</DateFirstPublished>
  <DateLastModified>2021-02-12</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000500167" url="/about-cancer/treatment/drugs/aminolevulinicacid">Aminolevulinic Acid Hydrochloride</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
